Graphic: corner
spacer
Graphic: corner
spacer spacer
nav left edge
nav right edge
spacer

Gene Therapy for Dogs affected with Canine Multifocal Retinopathy (CMR) - October 14, 2014

Gene therapy for CMR is being planned at the University of Pennsylvania School of Veterinary Medicine.

Breeds that are eligible for possible inclusion in these therapy trials are those for with OptiGen offers CMR testing:

  • Great Pyrenees
  • English mastiffs and mastiff derived breeds
  • Coton de Tulear
  • Lapponian Herder
All dogs must have clinically evident disease that can be documented photographically, and molecular defect confirmed by DNA testing.

If you are interested in participating, please contact Mrs. Lydia Melnyk at: lmelnyk@vet.upenn.edu 


spacer
Graphic: footer bar left
OptiGen®, LLC · Cornell Business & Technology Park · 767 Warren Road, Suite 300 · Ithaca, New York 14850
Tel: 607 257 0301 · Fax: 607 257 0353 · email: genetest@optigen.com or optigen@clarityconnect.com
Graphic: footer bar right
spacer spacer
spacer
spacer
spacer